DK1575559T3 - Doseringsaerosoler med lecithin som overfladeaktivt stof - Google Patents
Doseringsaerosoler med lecithin som overfladeaktivt stofInfo
- Publication number
- DK1575559T3 DK1575559T3 DK03799507T DK03799507T DK1575559T3 DK 1575559 T3 DK1575559 T3 DK 1575559T3 DK 03799507 T DK03799507 T DK 03799507T DK 03799507 T DK03799507 T DK 03799507T DK 1575559 T3 DK1575559 T3 DK 1575559T3
- Authority
- DK
- Denmark
- Prior art keywords
- lecithin
- surfactant
- dosage aerosols
- aerosols
- dosage
- Prior art date
Links
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 title abstract 2
- 239000000443 aerosol Substances 0.000 title abstract 2
- 229940067606 lecithin Drugs 0.000 title abstract 2
- 235000010445 lecithin Nutrition 0.000 title abstract 2
- 239000000787 lecithin Substances 0.000 title abstract 2
- 239000004094 surface-active agent Substances 0.000 title abstract 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000001282 iso-butane Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10260882A DE10260882B4 (de) | 2002-12-24 | 2002-12-24 | Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1575559T3 true DK1575559T3 (da) | 2006-11-27 |
Family
ID=32667543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03799507T DK1575559T3 (da) | 2002-12-24 | 2003-12-24 | Doseringsaerosoler med lecithin som overfladeaktivt stof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060073103A1 (da) |
| EP (1) | EP1575559B1 (da) |
| JP (1) | JP2006517190A (da) |
| CN (1) | CN1728984A (da) |
| AT (1) | ATE335467T1 (da) |
| AU (1) | AU2003300230A1 (da) |
| DE (2) | DE10260882B4 (da) |
| DK (1) | DK1575559T3 (da) |
| ES (1) | ES2270166T3 (da) |
| IL (1) | IL169356A0 (da) |
| TW (1) | TW200423969A (da) |
| WO (1) | WO2004058221A1 (da) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5292499A (en) * | 1990-09-11 | 1994-03-08 | University Of Wales College Of Cardiff | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
| GB9118830D0 (en) * | 1991-09-03 | 1991-10-16 | Minnesota Mining & Mfg | Medical aerosol formulations |
| WO1998034595A1 (de) * | 1997-02-05 | 1998-08-13 | Jago Research Ag | Medizinische aerosolformulierungen |
| US6017545A (en) * | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
| AU748867B2 (en) * | 1998-07-24 | 2002-06-13 | Jagotec Ag | Medicinal aerosol formulations |
| US6312665B1 (en) * | 1998-12-21 | 2001-11-06 | Generex Pharmaceuticals Incorporated | Aerosol formulations for buccal and pulmonary application |
| DE19911064A1 (de) * | 1999-03-12 | 2000-09-14 | Ig Spruehtechnik Gmbh | Dosieraerosole mit Isobutan als Treibmittel |
-
2002
- 2002-12-24 DE DE10260882A patent/DE10260882B4/de not_active Expired - Fee Related
-
2003
- 2003-12-18 TW TW092135946A patent/TW200423969A/zh unknown
- 2003-12-24 WO PCT/EP2003/014901 patent/WO2004058221A1/de not_active Ceased
- 2003-12-24 ES ES03799507T patent/ES2270166T3/es not_active Expired - Lifetime
- 2003-12-24 AU AU2003300230A patent/AU2003300230A1/en not_active Abandoned
- 2003-12-24 CN CNA2003801071841A patent/CN1728984A/zh active Pending
- 2003-12-24 EP EP03799507A patent/EP1575559B1/de not_active Expired - Lifetime
- 2003-12-24 US US10/540,648 patent/US20060073103A1/en not_active Abandoned
- 2003-12-24 DK DK03799507T patent/DK1575559T3/da active
- 2003-12-24 DE DE50304615T patent/DE50304615D1/de not_active Expired - Fee Related
- 2003-12-24 AT AT03799507T patent/ATE335467T1/de not_active IP Right Cessation
- 2003-12-24 JP JP2004563206A patent/JP2006517190A/ja active Pending
-
2005
- 2005-06-23 IL IL169356A patent/IL169356A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10260882A1 (de) | 2004-09-30 |
| DE50304615D1 (de) | 2006-09-21 |
| EP1575559A1 (de) | 2005-09-21 |
| EP1575559B1 (de) | 2006-08-09 |
| DE10260882B4 (de) | 2007-02-08 |
| AU2003300230A1 (en) | 2004-07-22 |
| TW200423969A (en) | 2004-11-16 |
| ATE335467T1 (de) | 2006-09-15 |
| CN1728984A (zh) | 2006-02-01 |
| US20060073103A1 (en) | 2006-04-06 |
| ES2270166T3 (es) | 2007-04-01 |
| JP2006517190A (ja) | 2006-07-20 |
| WO2004058221A1 (de) | 2004-07-15 |
| IL169356A0 (en) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| CY1111821T1 (el) | Φαρμακευτικες συνθeσεις οι οποιες περιλαμβανουν ενα οπιουχο αναλγητικο | |
| ATE291898T1 (de) | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason | |
| AP2003002916A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
| ATE342053T1 (de) | Formulierungen zur inhalation | |
| ES2189410T3 (es) | Formulacion farmaceutica en aerosol. | |
| WO2006015943A3 (en) | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof | |
| BR0207025B1 (pt) | derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo. | |
| NO20073244L (no) | Konjugeringsprodukt | |
| DE60311920D1 (de) | Aufgabevorrichtung mit Dosierkammer sowie Aerosolspender mit derselben | |
| NO992102D0 (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
| ECSP077126A (es) | Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores | |
| DE60031504D1 (de) | Fluticasonpropionat arzneizubereitung | |
| WO2003102012A3 (en) | New etonogestrel esters | |
| DE60324205D1 (de) | Wasserlöslicher behälter | |
| DE60136637D1 (en) | Topische polymere antimikrobielle emulsion | |
| AR038560A1 (es) | Una composicion antitranspirante/ desodorante | |
| ITRM20020477A1 (it) | Procedimento per la realizzazione di un fantoccio stereolitografato biomorfo, multicompartimentale e per esami multianalitici, e relativo dispositivo. | |
| DK1575559T3 (da) | Doseringsaerosoler med lecithin som overfladeaktivt stof | |
| NO20052478D0 (no) | Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse. | |
| NO20053110D0 (no) | 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler. | |
| IT1321165B1 (it) | Regolatore di pressione per gas . | |
| NO20053117D0 (no) | Cyklopenta[c]isoksazol-3-aminer anvendt som materialbeskyttelsesmidler. | |
| NO20030474D0 (no) | Demens-legemiddel som inneholder 2-aryl-8- oksodihydropurinderivater som denaktive bestanddel | |
| TW200724152A (en) | Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same |